Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 10;13(8):1818.
doi: 10.3390/cancers13081818.

Radical Resection for Locally Advanced Pancreatic Cancers in the Era of New Neoadjuvant Therapy-Arterial Resection, Arterial Divestment and Total Pancreatectomy

Affiliations
Review

Radical Resection for Locally Advanced Pancreatic Cancers in the Era of New Neoadjuvant Therapy-Arterial Resection, Arterial Divestment and Total Pancreatectomy

Yosuke Inoue et al. Cancers (Basel). .

Abstract

Aggressive arterial resection (AR) or total pancreatectomy (TP) in surgical treatment for locally advanced pancreatic cancer (LAPC) had long been discouraged because of their high mortality rate and unsatisfactory long-term outcomes. Recently, new chemotherapy regimens such as FOLFIRINOX or Gemcitabine and nab-paclitaxel have provided more adequate patient selection and local tumor suppression, justifying aggressive local resection. In this review, we investigate the recent reports focusing on arterial resection and total pancreatectomy for LAPC and discuss the rationale of such an aggressive approach in the treatment of PC. AR for LAPCs is divided into three, according to the target vessel. The hepatic artery resection is the simplest one, and the reconstruction methods comprise end-to-end, graft or transposition, and no reconstruction. Celiac axis resection is mainly done with distal pancreatectomy, which allows collateral arterial supply to the liver via the pancreas head. Resection of the superior mesenteric artery is increasingly reported, though its rationale is still controversial. Total pancreatectomy has been re-evaluated as an effective option to balance both the local control and postoperative safety. In conclusion, more and more aggressive pancreatectomy has become justified by the principle of total neoadjuvant therapy. Further technical standardization and optimal neoadjuvant strategy are mandatory for the global dissemination of aggressive pancreatectomies.

Keywords: arterial resection; neoadjuvant therapy; pancreatic cancer; total pancreatectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Reconstruction of the superior mesenteric artery. (A) Basic anatomy of relevant vessels in SMA resection. (B) Direct end-to-end anastomosis. (C) Transposition of SpA to be anastomosed with the distal stump of the SMA. (D) End-to-end anastomosis with graft interposition. (E) Graft interposition from the aorta to the distal stump of the SMA. (F) Combined resection and reconstruction of the HA and SMA using interposition grafts. HA, hepatic artery, SpA, splenic artery, GDA, gastroduodenal artery, SMA, superior mesenteric artery, MCA, middle colic artery and LGA, left gastric artery.
Figure 2
Figure 2
Reconstruction of the hepatic artery. (A) Basic anatomy of the relevant vessels in HA resection. (B) Direct end-to-end anastomosis. (C) Transposition of the MCA and RIPA to be anastomosed with the RHA and LHA. (D) Transposition of the SpA to be anastomosed with the proper HA. (E) Graft interposition from the aorta to the stump of the proper HA. HA, hepatic artery, RIPA, right inferior phrenic artery, SpA, splenic artery, GDA, gastroduodenal artery, SMA, superior mesenteric artery, MCA, middle colic artery, LGA left gastric artery, RHA, right hepatic artery and LHA, left hepatic artery.

References

    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J. Clin. 2019;69:7–34. doi: 10.3322/caac.21551. - DOI - PubMed
    1. Fortner J.G. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann. Surg. 1984;199:418–425. doi: 10.1097/00000658-198404000-00008. - DOI - PMC - PubMed
    1. Mollberg N., Rahbari N.N., Koch M., Hartwig W., Hoeger Y., Büchler M.W., Weitz J. Arterial resection during pancreatectomy for pancreatic cancer: A systematic review and meta-analysis. Ann. Surg. 2011;254:882–893. doi: 10.1097/SLA.0b013e31823ac299. - DOI - PubMed
    1. Karpoff H.M., Klimstra D.S., Brennan M.F., Conlon K.C. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch. Surg. 2001;136:44–47; discussion 48. doi: 10.1001/archsurg.136.1.44. - DOI - PubMed
    1. Conroy T., Desseigne F., Ychou M., Bouche O., Guimbaud R., Becouarn Y., Adenis A., Raoul J.L., Gourgou-Bourgade S., de la Fouchardiere C., et al. Folfirinox versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med. 2011;364:1817–1825. doi: 10.1056/NEJMoa1011923. - DOI - PubMed

LinkOut - more resources